Product NDC: | 15127-105 |
Proprietary Name: | Senna-Lax |
Non Proprietary Name: | Sennosides |
Active Ingredient(s): | 8.6 mg/1 & nbsp; Sennosides |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 15127-105 |
Labeler Name: | Stephen L. LaFrance Pharmacy, Inc. |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part334 |
Marketing Category: | OTC MONOGRAPH NOT FINAL |
Start Marketing Date: | 19950127 |
Package NDC: | 15127-105-01 |
Package Description: | 1 BOTTLE, PLASTIC in 1 CARTON (15127-105-01) > 100 TABLET in 1 BOTTLE, PLASTIC |
NDC Code | 15127-105-01 |
Proprietary Name | Senna-Lax |
Package Description | 1 BOTTLE, PLASTIC in 1 CARTON (15127-105-01) > 100 TABLET in 1 BOTTLE, PLASTIC |
Product NDC | 15127-105 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Sennosides |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 19950127 |
Marketing Category Name | OTC MONOGRAPH NOT FINAL |
Labeler Name | Stephen L. LaFrance Pharmacy, Inc. |
Substance Name | SENNOSIDES A AND B |
Strength Number | 8.6 |
Strength Unit | mg/1 |
Pharmaceutical Classes |